Jewel Mullen's guest appearances

Jewel Mullen

Managed Care Cast

WTMJ Conversations & WTMJ Features

The Big 550 KTRS

Alex Stone

Andrew Campanella

David Zucker

Aaron Katersky

Jerry Stiller

Al Tompkins

Frank Caliendo

Jean Kiddoo

Jim Ryan

Michael Johnson

Jim Copland

Sean Duffy

Joe Brown

Steve Byrne

Steve Siebold

OwlTail

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

See Privacy Policy at <a href="https://art19.com/privacy" rel="nofollow" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="nofollow" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.

WWMN Interview: Dr. Jewel Mullen 12-19-20

Recently released vaccine data from both Pfizer and Moderna indicate encouraging steps forward in the global fight against coronavirus disease 2019 (COVID-19). But both vaccines are still a long way from becoming readily available to the wider public, prompting the question, who should be prioritized once doses become available? To provide guidance on this front, The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) requested The National Academies of Science, Engineering, and Medicine (NASEM) to construct a framework assisting US policymakers and global health communities to plan for an equitable allocation of a COVID-19 vaccine. On this episode of Managed Care Cast, we speak with Jewel Mullen, (MD, MPH) the associate dean for health equity and associate professor of population health and internal medicine at the University of Texas at Austin, Dell Medical School. Mullen is the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS) and a member of the National Academies committee which developed the framework for vaccine allocation.  Mullen discusses criteria used to prioritize vaccine recipients, barriers to equitable distribution, and the role of misinformation in the push for an effective COVID-19 vaccine.Read more:Pfizer Says Vaccine 90% Effective; Biden Team Announces COVID-19 Transition Panel: https://www.ajmc.com/view/pfizer-says-vaccine-90-effective-biden-team-announces-covid-19-transition-panelStudy Backs Decision to Move Forward With Pfizer Vaccine Candidate: https://www.ajmc.com/view/study-backs-decision-to-move-forward-with-pfizer-vaccine-candidateModerna SARS-CoV-2 Vaccine Elicits Response in Older Adults: https://www.ajmc.com/view/moderna-sars-cov-2-vaccine-elicits-response-in-older-adultsDr Maura Abbott: Talk to Your Patients About Their Vaccine Fears: https://www.ajmc.com/view/dr-maura-abbott-talk-to-your-patients-about-their-vaccine-fearsDr Maura Abbott: COVID-19 Vaccine Development Process Is Safe Despite a Quicker Timeline: https://www.ajmc.com/view/dr-maura-abbott-covid-19-vaccine-development-process-is-safe-despite-a-quicker-timelineDr Victoria Smith on Experience Taking Part in a COVID-19 Vaccine Trial: https://www.ajmc.com/view/dr-victoria-smith-on-experience-taking-part-in-a-covid-19-vaccine-trial

Recently released vaccine data from both Pfizer and Moderna indicate encouraging steps forward in the global fight against coronavirus disease 2019 (COVID-19). But both vaccines are still a long way from becoming readily available to the wider public, prompting the question, who should be prioritized once doses become available? To provide guidance on this front, The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) requested The National Academies of Science, Engineering, and Medicine (NASEM) to construct a framework assisting US policymakers and global health communities to plan for an equitable allocation of a COVID-19 vaccine. On this episode of Managed Care Cast, we speak with Jewel Mullen, (MD, MPH) the associate dean for health equity and associate professor of population health and internal medicine at the University of Texas at Austin, Dell Medical School. Mullen is the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS) and a member of the National Academies committee which developed the framework for vaccine allocation. Mullen discusses criteria used to prioritize vaccine recipients, barriers to equitable distribution, and the role of misinformation in the push for an effective COVID-19 vaccine. Read more: Pfizer Says Vaccine 90% Effective; Biden Team Announces COVID-19 Transition Panel: <a href="https://www.ajmc.com/view/pfizer-says-vaccine-90-effective-biden-team-announces-covid-19-transition-panel" rel="nofollow" target="_blank">https://www.ajmc.com/view/pfizer-says-vaccine-90-effective-biden-team-announces-covid-19-transition-panel</a> Study Backs Decision to Move Forward With Pfizer Vaccine Candidate: <a href="https://www.ajmc.com/view/study-backs-decision-to-move-forward-with-pfizer-vaccine-candidate" rel="nofollow" target="_blank">https://www.ajmc.com/view/study-backs-decision-to-move-forward-with-pfizer-vaccine-candidate</a> Moderna SARS-CoV-2 Vaccine Elicits Response in Older Adults: <a href="https://www.ajmc.com/view/moderna-sars-cov-2-vaccine-elicits-response-in-older-adults" rel="nofollow" target="_blank">https://www.ajmc.com/view/moderna-sars-cov-2-vaccine-elicits-response-in-older-adults</a> Dr Maura Abbott: Talk to Your Patients About Their Vaccine Fears: <a href="https://www.ajmc.com/view/dr-maura-abbott-talk-to-your-patients-about-their-vaccine-fears" rel="nofollow" target="_blank">https://www.ajmc.com/view/dr-maura-abbott-talk-to-your-patients-about-their-vaccine-fears</a> Dr Maura Abbott: COVID-19 Vaccine Development Process Is Safe Despite a Quicker Timeline: <a href="https://www.ajmc.com/view/dr-maura-abbott-covid-19-vaccine-development-process-is-safe-despite-a-quicker-timeline" rel="nofollow" target="_blank">https://www.ajmc.com/view/dr-maura-abbott-covid-19-vaccine-development-process-is-safe-despite-a-quicker-timeline</a> Dr Victoria Smith on Experience Taking Part in a COVID-19 Vaccine Trial: <a href="https://www.ajmc.com/view/dr-victoria-smith-on-experience-taking-part-in-a-covid-19-vaccine-trial" rel="nofollow" target="_blank">https://www.ajmc.com/view/dr-victoria-smith-on-experience-taking-part-in-a-covid-19-vaccine-trial</a>

Dr Jewel Mullen Discusses NASEM's Framework For an Equitable Distribution of a COVID-19 Vaccine